Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric mucosal proteins and enzymes represent a heterogeneous group of molecular entities within the stomach lining that are vital for digestion and epithelial defense. This category includes the H+/K+ ATPase (proton pump), which mediates the final step of acid secretion, and enzymes such as pepsinogen and gastric lipase that initiate the breakdown of dietary proteins and fats (StatPearls, 2023). Additionally, structural proteins like mucins (MUC5AC, MUC6) and trefoil factors are essential for maintaining the gastric mucus-bicarbonate barrier, which protects the mucosa from the corrosive effects of luminal acid and proteases (NCBI, 2022). These proteins serve as primary targets for pharmacological intervention; for instance, proton pump inhibitors (PPIs) covalently bind to the H+/K+ ATPase to treat acid-peptic disorders, while cytoprotective agents like sucralfate interact with exposed mucosal proteins to form a physical shield over ulcerated tissue (StatPearls, 2023). Understanding the function and regulation of these proteins is crucial for managing gastrointestinal conditions such as peptic ulcer disease, GERD, and chronic gastritis.
The primary mechanisms of action for drugs targeting these proteins include the irreversible inhibition of the gastric H+/K+ ATPase (proton pump) to suppress hydrochloric acid secretion (StatPearls, 2023); the formation of a protective physical barrier by binding to mucosal proteins like albumin and fibrinogen at ulcer sites (NIH, 2022); and the stimulation of protective factors such as mucus and bicarbonate secretion (PubMed, 2021).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric mucosal proteins and enzymes.